Introduction
Within an integrated organization, the immune system accommodates a variety of signals originating from neuroendocrine system 1 . Indeed, the immunomodulatory potency of hormones and neuropeptides has been extensively reported 2 . In turn, cytokines mainly produced by immune cells modify the neuronal activity, as exemplified by the effect of IL-1 on the central nervous system 3 . These communication pathways have been highlighted by the characterization on immune and nervous cells of common receptors for cytokines, hormones and neuropeptides 4, 5 . The interactions between nervous and immune systems are emphasized by the ability of immune cells and neurons to synthesize cytokines, neuropeptides and hormones 6, 7 . It has been reported that lymphocytes infiltrating inflamed tissues released ß-endorphin which was responsible for an analgesia by acting on opioid receptors (seven transmembrane segment Gi/o-protein-coupled receptors) expressed on peripheral afferent nerves 8 .
Opioids constitute a good model for a neuro-immunological relationship because their effects are not restricted to the nervous system but stretch to the immune system. Some immunological functions such as natural killer activity, lymphocyte proliferation, macrophage motility and secretion of proinflammatory cytokines are reduced by opioids including morphine [9] [10] [11] [12] [13] . In vivo, morphine effects are mainly mediated by µ-opioid receptor 10, 14 . Using mice injected with morphine or submitted to stressful conditions, Yin and collaborators clearly demonstrated that opioids promoted
Fas-mediated lymphocyte apoptosis in vivo 15, 16 .
In normal conditions a large part of circulating immunoglobulins are autoreactive. Antibody activities against soluble, membrane and intracellular self-antigens have been described in normal humans and animals 17 .
Among the number of physiological roles attributed to these so-called natural antibodies, only their contribution to organism protection as first line of defense against pathogens has been clearly established 18, 19 . The immunoregulatory role of natural autoantibodies has been proposed based on the description of their ability to prevent ligand-receptor binding involved in immune processes by neutralizing ligands and/or receptors 20, 21 .
We have previously shown that antibodies directed against the human µ-opioid receptor (hMOR) were present within pools of normal human IgG. These anti-hMOR IgG autoantibodies displayed a specific agonistic activity due to their simultaneous binding on the first and third extracellular loops of the receptor 22, 23 . In this study, anti-hMOR IgG autoantibodies directed towards both the first and the third extracellular loops of the receptor were found in the serum of all healthy blood donors examined. We took advantage of the high sequence homology only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From between mouse and human µ opioid receptor extracellular loops to assess the potency of anti-hMOR IgG to sensitize immune cells to Fas (CD95)-mediated apoptosis in mice. Immunization against the hMOR was performed by injecting mice with recombinant cells in the absence of adjuvant. Hypodiploid DNA fluorescence was used to assess apoptosis levels. Spleen cells from mice immunized against recombinant hMOR/CHO cells were sensitized to Fasmediated apoptosis while those from mice injected with either PBS or untransfected CHO cells were not.
Sensitization to Fas-mediated apoptosis in recombinant hMOR/CHO-injected mice was associated with a reduced number of splenocytes as compared to CHO cell-injected control mice. Furthermore, splenocytes originating from mice passively transferred either with IgG from mice immunized against hMOR/CHO cells or with IgG directed against the first and the third extracellular loops of the hMOR were sensitized to Fas-mediated apoptosis.
Taken together, our data show that in normal conditions anti-hMOR IgG autoantibodies are expressed in human sera and could participate to the control of lymphocyte proliferation by promoting Fas-mediated apoptosis.
only.
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Materials and Methods

Source of human IgG
Venous blood was collected from twenty two regular healthy donors without recent pathological events and with no history of any drug abuse. Donors were free of recent chirurgical, antibiotic and anti-inflammatory treatment.
IgG fractions were prepared from sera by affinity chromatography on protein G column (Pharmacia Fine Chemicals, Uppsala, Sweden). A pool of immunoglobulin G prepared from plasma of 15,000 normal donors was also used as a source of human IgG (Sandoglobulin ® , NOVARTIS, Basel, Switzerland). F(ab') 2 fragments were prepared from IgG by pepsin digestion (2% wt/wt) (Sigma) in sodium-acetate 0.2 M pH 4.1 at 37°C for 18 hours. F(ab') 2 fragments were free of intact IgG as assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Purification of human anti-hMOR antibodies
Antibodies directed against hMOR were affinity-purified on a recombinant hMOR/CHO cell clone as previously described 22 . Briefly, IgG or F(ab') 2 fragments were incubated with confluent hMOR/CHO cells for 1 h at 37°C. After washing, bound IgG or F(ab') 2 antibodies were eluted using sodium-citrate 0.1 M, pH 3.5 and recovered by purification on either protein G or Sepharose-bound sheep anti-human IgG F(ab') 2 -specific antibodies (Valbiotech, Paris, France) affinity columns. In order to remove antibody reactivity towards CHO-K1 cells, a subsequent incubation with untransfected CHO-K1 cells followed by the appropriate chromatography was performed.
Affinity-purified anti-hMOR IgG or F(ab') 2 antibodies were free of contaminant proteins as assessed by comparing SDS-PAGE and goat anti-human IgG F(ab') 2 -specific antibody and/or goat anti-human Fc antibody (Jackson Immunoresearch Lab., West Grove, PA) immunoblots. Antibodies reactive with non-transfected CHO-K1 cells were prepared from F(ab') 2 fragments as described above. Anti-laminin IgG and anti-laminin F(ab') 2 were purified from normal human IgG pool by affinity chromatography on a column of Sepharose-bound laminin as described elsewhere 24 .
Cytofluorometric analysis of anti-hMOR antibody activity
Recombinant hMOR/CHO cells and untransfected CHO-K1 cells (10 6 ) were incubated with either IgG or F(ab') 2 fragments for 45 min at 4°C. After washing, the cells were stained with biotin-labeled goat anti-human IgG only.
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For inhibition experiments, two peptides corresponding to the hMOR extracellular loop
25 and the encephalitogenic peptide (G- , were used. Antibodies were incubated with 20 µg/ml of peptides for 1 hour at 37°C before adding to the cells for 45 min at 4°C. Residual antibody binding was then examined.
Cytofluorometric analysis of spleen cell subpopulations
After red blood cell lysis with ammonium chloride 150 mM, potassium carbonate 10 mM and EDTA 0. 
Immunization of mice
Eight week-old female BALB/c mice were purchased from Janvier (Le Genest Saint Isle, France 
Determination of anti-hMOR EL IgG antibody activity
ELISA plates were coated with 10 µg/ml of either hMOR EL1 or hMOR EL3 peptide in PBS overnight at 4°C. Uncoated sites were saturated with PBS containing 1% gelatin 90 min at 37°C. Plates were washed before incubation for 60 min at 37°C with antibody samples. Bound antibodies were revealed using biotin-labeled goat antimouse Fc -specific antibodies (Jackson Immunoresearch Lab., West Grove, PA) and peroxidase-labeled streptavidin (Amersham, Slough, UK).
For inhibition experiments, IgG antibodies were incubated with serial dilutions of peptides for 60 min at 37°C and residual IgG binding was measured.
IgG transfers
IgG purified from normal and immunized mice were intravenously injected into naive BALB/c mice.
Twenty-four hours later, mice were sacrificed. All experiments were conducted in conformity with guiding principles for the care and use of animals.
Induction of Fas (CD95)-mediated apoptosis
Mouse splenocytes were prepared by crushing the spleen. After washing, splenocytes were enumerated by trypan blue dye exclusion. After red blood cell lysis, 5. (Fig. 1A) . To be evidenced anti-hMOR antibodies required to be affinity-purified from total IgG preparations. IgG from all individuals were submitted to a purification procedure including an isolation of IgG directed against recombinant hMOR/CHO cell clone followed by a depletion of IgG which react with untransfected CHO-K1 cells 22 . As shown in Figure 1B , serum IgG from all healthy individuals without sex discrimination contained autoantibodies directed against the hMOR. Mainly due to two individuals, an apparent but not significant higher IgG binding activity to hMOR was observed in males as compared with females.
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Figure 2
By contrast, none of the peptides neutralized the binding of affinity-purified anti-CHO F(ab') 2 fragments to recombinant hMOR/CHO cells (Fig. 2D ). Anti-hMOR antibody specificity assessment was then performed for IgG 
Figure 3
Taken together, these data show that anti-hMOR antibodies with potential agonistic activity are commonly present in the serum of healthy blood donors.
Anti-hMOR IgG sensitize splenocytes to CD95 (Fas)-mediated apoptosis
Recent reports have clearly demonstrated that exogenous (morphine) as well as endogenous opioids promoted Fas (CD95)-mediated lymphocyte apoptosis 15, 16 . By analogy, we investigated the ability of anti-hMOR autoantibodies to generate similar effects. For this purpose, we developed a model in which anti-hMOR antibodies were raised by immunizing mice. The pro-apoptotic effect of induced-anti-hMOR (auto)antibodies could be explored on mouse splenocytes because IgG-induced MOR activation is dependent on antibody binding to the first and the (Fig.5 B) . The number of thymocytes was not modified by immunization procedures (Fig.5 C) .
Figure 5
The sensitization of splenocytes to Fas-mediated apoptosis observed in hMOR/CHO-injected mice was not associated with an increase in Fas antigens on the surface of CD4 as well as CD8 T lymphocytes as assessed by cytofluorometry (Fig.6 ). For
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These data suggesting that immunization of mice against hMOR generated agonistic opioid-like antibodies responsible for an increased sensitivity of lymphocytes to CD95(Fas)-mediated apoptosis were strengthened by passive IgG transfer experiments. Splenocytes from mice intravenously injected with IgG purified from pooled sera of mice immunized against hMOR/CHO which displayed splenocyte sensitization to apoptosis in vitro were more susceptible to anti-Fas antibody-mediated apoptosis than those originating from mice which received IgG from PBSor CHO-injected mice (Fig. 7) .
Figure 7
The pro-apoptotic effect of IgG antibodies directed against the first and third extracellular loops of the hMOR was then investigated. BALB/c mice were immunized against peptides corresponding to the amino-acid sequences of either the first (hMOR EL1) or the third (hMOR EL3) extracellular loop of the receptor. The IgG binding activity measured in serum of immunized mice was specific to the peptide used as immunogen. Anti-hMOR EL1 IgG bound to the insolubilized hMOR EL1 peptide but not to the hMOR EL3 peptide. Reciprocally, anti-hMOR EL3 IgG bound to the hMOR EL3 peptide but not to the hMOR EL1 peptide (Fig. 8A and 8C) . The ability of anti- For figure 8B , the anti-hMOR EL1 antibody activity was equally neutralized by the hMOR EL1 peptide and a substitute of the mouse MOR EL1 amino-acid sequence. Peptides corresponding to the human and the mouse MOR EL3 amino-acid sequences inhibited the binding of anti-hMOR EL3 IgG to hMOR EL3 to similar level (Fig. 8D) . (Fig. 8B and 8D ).
Figure 8
Anti-hMOR EL1 IgG and anti-hMOR EL3 IgG preparations were then assessed alone or combined for their potency to favor lymphocyte apoptosis in vivo. When passively transferred into naive mice, normal IgG and antihMOR EL1 IgG had no effect on Fas-mediated splenocyte apoptosis. When compared with mice injected with normal IgG and anti-hMOR EL1 IgG, only mice injected with anti-hMOR EL1 IgG together with anti-hMOR EL3
IgG exhibited a significant splenocyte sensitization to Fas-mediated apoptosis. This suggests an additive contribution of these two antibody preparations with an essential contribution of anti-hMOR EL3 IgG (p = 0.02, Mann-Whitney U test), (Fig. 9 ). For
Figure 9
Taken together, these data show that anti-hMOR autoantibodies present in serum of healthy blood donors could contribute to sensitivity of immune cells to Fas (CD95) mediated apoptosis. Alternatively, the presence of anti-hMOR antibodies could emerge from a secondary anti-idiotypic response against anti-opiate antibodies 30 , generated by self-opioid peptides and/or opioid peptides such as casomorphins released from bovine milk casein during digestion 31 . Our inability to isolate anti-MOR IgG from pooled sera of normal mice whose nutritional and medicinal diet differs from humans strengthens the role of environmental antigens for the occurrence of detectable anti-hMOR IgG in healthy blood donors. Another point of view is that although external stimuli may enhance the production of some cross-reactive natural autoantibodies, these latter occur independently of environmental stimuli
32
. Accordingly, it has been considered that disease-associated autoantibodies may emerge from natural autoantibody repertoire 33 . In this context, characterization of agonistic anti-G protein-coupled receptor autoantibodies in a number of pathological situations including Graves'disease 34 , preeclampsia 35 , neonatal lupus congenital heart block 36 and schizophrenia 37 may presume that this kind of autoantibodies including anti-hMOR autoantibodies are a common feature of the natural autoantibody repertoire.
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The presence of anti-hMOR IgG antibodies with a potential agonistic activity in the serum of all randomly selected healthy donors led us to examine their putative physiological role by investigating the consequences of their over-expression on mouse immune status. Taking advantage of the high sequence homology between human and mouse extracellular loops of the MOR, we immunized mice against hMOR to raise antibodies recognizing mouse host receptors. MOR expressed on immune cell surface constituted the more accessible targets for circulating IgG antibodies which are unable to cross the blood-brain barrier. We focused our investigation on lymphocyte apoptosis. For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From observed. The apparent discrepancy with Yin et collaborators' previous report 15 showing an up-regulation of Fas in morphine-treated animals, could be attributed either to the lower discriminatory potency of the cytofluorometry method used here as compared to northern-blot analysis, or to the absence of straight relationship between mRNA synthesis and protein expression. Alternatively, the increase in mRNA encoding for Fas receptor observed by Yin and collaborators in whole spleen cell from morphine-treated mice could be due to an enhancement of Fas expression on other cells than T lymphocytes 44 . The nature of spleen cells, which could directly interact with µ-opioid agonistic ligands, is still unclear. Albeit morphine acts on T cell hybridomas 15, 45 , MOR mRNA has only been clearly evidenced on macrophages [46] [47] [48] . Thus, the effect of morphine on both spleen cell sub-populations presumes either that µ-opioid receptor is expressed on all lymphocyte subsets or that Fas-mediated lymphocyte apoptosis is initiated on macrophages and then spreads out to lymphocytes via the release of mediators such as nitric oxide able to promote up -regulation of Fas 49, 50 , in the case of an expression of MOR restricted to macrophages.
By contrast to splenocytes, thymocytes were not affected by the immunization of mice against hMOR/CHO cells. This observation rules out a direct mechanism involving the µ-opioid receptor. Our results are in agreement with previous reports showing that adrenalectomy abolished the apoptotic effect of morphine on thymocytes but not on splenocytes 16, 51, 52 . Moreover, only and k opioid receptor subclasses have been described on thymic cells [53] [54] [55] .
Taken together, these findings indicate that under normal conditions or within IgG pool for therapeutic use, anti-hMOR IgG autoantibodies could participate to immunoregulatory processes by favoring Fasmediated control of the immune response.
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